Occlusion Clinical Trials in Beijing
6 recruitingBeijing, China
Showing 1–6 of 6 trials
Recruiting
Phase 4
Tenecteplase Before Interhospital Transfer in Acute Basilar Artery Occlusion at 4.5 to 24 Hours
Acute Ischemic StrokeBasilar Artery Occlusion
Xuanwu Hospital, Beijing316 enrolled1 locationNCT07203625
Recruiting
Real World Evidence in China: Faricimab Use in Diabetic Macular Edema, Retinal Vein Occlusion, and Neovascular Age-Related Macular Degeneration (The Farseeing Study)
Neovascular Age-related Macular DegenerationDiabetic Macular EdemaRetinal Vein Occlusion
Hoffmann-La Roche1,000 enrolled41 locationsNCT06439576
Recruiting
Cerebral Large Vessel Occlusion Stroke Multiomics Biosample Cohort
Acute Ischemic StrokeLarge Vessel Occlusion
First Affiliated Hospital of Wannan Medical College500 enrolled5 locationsNCT06963489
Recruiting
Not Applicable
Extracranial-intracranial Bypass Surgery for Symptomatic Chronic Middle Cerebral Artery Occlusion: the CMOSS-2 Trial
Symptomatic Chronic Middle Cerebral Artery OcclusionInfarction, Middle Cerebral Artery
Xuanwu Hospital, Beijing420 enrolled1 locationNCT05899582
Recruiting
Revascularization for Symptomatic Non-acute Carotid Artery Occlusion
Non-acute Carotid Artery Occlusion
Xuanwu Hospital, Beijing1,000 enrolled2 locationsNCT06303414
Recruiting
Not Applicable
To Evaluate Whether IVUS-guided Drug-eluting Stent (DES) Implantation Leads to Better Clinical Outcomes Compared to Conventional Angiography in the Treatment of Chronic Complete Occlusion (CTO) Disease.
Chronic Total Occlusion of Coronary Artery
CCRF Inc., Beijing, China1,448 enrolled1 locationNCT04944615